Pomaglumetad
id:
pomaglumetad-225-553520
title:
Pomaglumetad
text:
Pomaglumetad (LY-404,039) is an amino acid analog drug that acts as a highly selective agonist for the metabotropic glutamate receptor group II subtypes mGluR2 and mGluR3. Pharmacological research has focused on its potential antipsychotic and anxiolytic effects. Pomaglumetad is intended as a treatment for schizophrenia and other psychotic and anxiety disorders by modulating glutamatergic activity and reducing presynaptic release of glutamate at synapses in limbic and forebrain areas relevant to
brand slug:
wiki
category slug:
encyclopedia
description:
Drug, used as a treatment for schizophrenia
original url:
https://en.wikipedia.org/wiki/Pomaglumetad
date created:
2009-07-16T08:05:58Z
date modified:
2024-09-14T12:59:01Z
main entity:
{"identifier":"Q6460431","url":"https://www.wikidata.org/entity/Q6460431"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/0f/Pomaglumetad.svg","width":72,"height":86}
fields total:
13
integrity:
16